anhydroecgonine methyl ester has been researched along with tecastemizole in 1 studies
| Studies (anhydroecgonine methyl ester) | Trials (anhydroecgonine methyl ester) | Recent Studies (post-2010) (anhydroecgonine methyl ester) | Studies (tecastemizole) | Trials (tecastemizole) | Recent Studies (post-2010) (tecastemizole) |
|---|---|---|---|---|---|
| 52 | 0 | 13 | 18 | 0 | 3 |
| Protein | Taxonomy | anhydroecgonine methyl ester (IC50) | tecastemizole (IC50) |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.028 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianucci, AM; Calderone, V; Coi, A; Massarelli, I; Testai, L | 1 |
1 other study(ies) available for anhydroecgonine methyl ester and tecastemizole
| Article | Year |
|---|---|
Identification of "toxicophoric" features for predicting drug-induced QT interval prolongation.
Topics: Amino Acid Sequence; Heart; Humans; Models, Molecular; Molecular Sequence Data; Molecular Structure; Protein Subunits; Sequence Alignment; Structure-Activity Relationship; Trans-Activators; Transcriptional Regulator ERG | 2008 |